Global chemotherapy demands: a prelude to equal access
Menée à partir des données GLOBOCAN 2018 portant sur l'incidence de 29 types de cancers dans 183 pays et sur des projections d'incidence jusqu'en 2040, cette étude présente une estimation des besoins en termes de chimiothérapies et de ressources humaines (médecins et oncologues) pour traiter les patients
Chemotherapy is a crucial component of cancer care. In The Lancet Oncology, Brooke Wilson and colleagues report chemotherapy demands and physician workforce requirements for 2018 and projections for 2040. The authors used population-based cancer data for patient characteristics and stage distribution in Australia and the USA, together with existing guidelines for cancer management to define indications for chemotherapy, to compute site-specific chemotherapy utilisation estimates, which were subsequently mapped to GLOBOCAN estimates of new cancer cases for 2018 and predictions for 2040. The authors estimated that 9 782 783 (57%) of 17 036 902 patients with cancer worldwide required first-line chemotherapy in 2018.
The Lancet Oncology , commentaire, 2018